左心室辅助装置撤除后心脏恢复:完全装置取出联合心室补片成形术经验
该研究评估完全取出左心室辅助装置(LVAD)联合心室双补片成形术的方案,纳入12例心肌恢复患者,中位LVAD支持10个月,撤除前左室射血分数从植入时15%升至50%(P=0.0025),30天生存率100%,1年生存率91.7%,无主要不良心脑血管事件,长期心功能维持。
要点
- 完全LVAD取出联合心室双补片成形术可行,围术期安全。
- 12例心肌恢复患者撤除后30天生存100%,1年生存91.7%。
- 随访期间NYHA心功能分级和心室功能保持稳定。
核心结论
- 完全LVAD取出联合心室补片成形术可行且长期结果稳定。
研究设计与样本
- 单中心研究,纳入所有在本机构取出LVAD的患者,共12例。
- 取出手术包括移除驱动线、泵壳、缝合环和流出道血管,心室壁用双补片成形术重建。
- 分析聚焦手术和术后结局参数,包括全因死亡和主要不良心脑血管事件。
主要发现
- 12例患者中HVAD 5例、HeartMate II 3例、HeartMate 3 4例;中位年龄40岁(IQR 33-52岁),50%为男性。
- 主要心衰病因:心肌炎5例、扩张型心肌病4例、中毒性心肌病2例、瓣膜性心衰1例。
- 中位LVAD支持时间10个月(IQR 8.5-30个月)。
- 中位左室射血分数从LVAD植入时15%(IQR 13-18%)升至撤除前50%(IQR 45-50%),P=0.0025。
- 30天生存率100%,1年生存率91.7%;术后中位13天(IQR 10-18天)全部出院,无主要不良心脑血管事件。
临床怎么用
- 对LVAD后心肌恢复患者,可考虑完全取出装置联合心室补片成形术以消除感染和血栓风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Myocardial recovery is a rare phenomenon in left ventricular assist device (LVAD) therapy. Surgical LVAD removal is associated with the risk of cardiac failure, and the individual evaluation of sufficient myocardial recovery is crucial. Thus, complete device explantation is not consistently performed to minimize perioperative risk. However, the remaining ventricular assist device components bear significant risks of infection or thrombosis. Therefore, we developed this study to evaluate a complete LVAD explantation protocol. METHODS: All patients in our institution who had an LVAD explanted were enrolled in the study. Explant surgery involved removal of the driveline, pump housing, sewing ring and outflow graft. The ventricular wall was reconstructed by double patch plasty. Our analysis focused on surgical and postoperative outcome parameters, including all-cause mortality and major adverse cardiac and cerebrovascular events. RESULTS: A total of 12 patients (HVAD, n = 5; HeartMate II, n = 3; HeartMate 3, n = 4) had myocardial recovery and qualified for our LVAD explantation study protocol [median age: 40 years, interquartile range (IQR) 33-52 years; 50% men]. Primary heart failure aetiology: myocarditis (n = 5), dilated cardiomyopathy (n = 4), toxic cardiomyopathy (n = 2) and valvular heart failure (n = 1). The median average duration on LVAD was 10 months (25-75%: IQR 8.5-30 months). The median left ventricular ejection fraction was 15% (IQR 13-18%) at LVAD implantation and 50% (IQR 45-50%) before LVAD explantation (P = 0.0025).The 30-day survival was 100%. The 1-year survival was 91.7%. All patients were discharged after a median 13 days (IQR 10-18 days) postoperatively. No patient had major adverse cardiac and cerebrovascular events. The New York Heart Association functional class remained consistent during the follow-up period (median New York Heart Association functional class: II, IQR II-II class) including preservation of ventricular function. CONCLUSIONS: Complete LVAD explantation with ventricular patch plasty is feasible and has consistent long-term results.
引用
- Gyoten T, Rojas SV, Fox H, et al. Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty. Eur J Cardiothorac Surg. 2021. PMID: 33367693. doi:10.1093/ejcts/ezaa461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。